Last week the United States Food and Drug Administration approved a new drug which is the most expensive one in the world and costs $3.5 million or more than Rs.28 crores per treatment.
The new drug Hemgenix is manufactured by CSL Behring and it is a gene therapy that treats haemophilia B – a genetic bleeding disorder in which patients are unable to produce a protein required to create blood clots.
This disorder affects 1 in 40,000 people in the world, most of whom are men.
The typical treatment for this disorder is routine intravenous infusions that help to maintain sufficient levels of the missing or deficient clotting factor. In the case of this new gene treatment, there is one-time IV infusion.
In a statement, Dr. Peter Marks, Director of the FDA’s Center for Biologics Evaluation and Research, described the therapy as representing an “important progress in the development of innovative therapies for those experiencing a high burden of disease associated with this form of haemophilia.”
Earlier, the most expensive drug in the US was Zolgensma which treats spinal muscular atrophy and is priced at $2.1 million for a course of treatment.
A group of 223 Hindu pilgrims from the Sindh province of Pakistan embarked on a…
External Affairs Minister S Jaishankar on Sunday said that Pakistan-occupied Kashmir is part of India…
As the war between Russia and Ukraine continues with Kremlin troops being relentless in their…
Taiwan's Ministry of Defence (MND) said it detected seven Chinese military aircraft and five naval…
Security personnel on Sunday morning launched a massive manhunt following a terrorist attack on an…
External Affairs Minister S Jaishankar on Saturday said that India has "very strongly countered" China…